For example, Tizabi et al. [23] suggested that “nicotine itself, through its interaction with the nicotinic cholinergic system, as well as ACE2, may not only be of use in a variety of neuropsychiatric and neurodegenerative diseases, but may also be of potential use in COVID-19”. The gene discussed is ACE2; the disease is COVID-19.